WallStreetZenWallStreetZen

NASDAQ: ADMA
Adma Biologics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ADMA

Based on 3 analysts offering 12 month price targets for Adma Biologics Inc

Min Forecast
$25.00+27.29%
Avg Forecast
$25.33+28.99%
Max Forecast
$26.00+32.38%

Should I buy or sell ADMA stock?

Based on 3 analysts offering ratings for Adma Biologics Inc.

Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ADMA's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ADMA as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their ADMA stock forecasts and price targets.

ADMA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-04
lockedlocked$00.00+00.00%2024-11-08
lockedlocked$00.00+00.00%2024-11-08

1 of 1

Forecast return on equity

Is ADMA forecast to generate an efficient return?

Company
98.04%
Industry
153.19%
Market
81.87%
ADMA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ADMA forecast to generate an efficient return on assets?

Company
70.02%
Industry
36.07%
ADMA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ADMA earnings per share forecast

What is ADMA's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$0.71-16.47%
Avg 2 year Forecast
$0.93+9.41%
Avg 3 year Forecast
$1.13+32.94%
ADMA's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

ADMA revenue forecast

What is ADMA's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$495.8M+16.26%
Avg 2 year Forecast
$611.5M+43.39%
Avg 3 year Forecast
$744.5M+74.58%
ADMA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ADMA earnings growth forecast

How is ADMA forecast to perform vs Biotechnology companies and vs the US market?

Company
10.07%
Industry
13.28%
Market
18.17%
ADMA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
ADMA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
ADMA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

ADMA revenue growth forecast

How is ADMA forecast to perform vs Biotechnology companies and vs the US market?

Company
20.25%
Industry
65.48%
Market
10.37%
ADMA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ADMA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ADMA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ADMA$19.64$25.33+28.99%Strong Buy
KRYS$161.91$222.80+37.61%Strong Buy
IONS$28.51$56.33+97.59%Buy
CYTK$37.93$82.44+117.36%Strong Buy
NUVL$69.95$114.67+63.93%Strong Buy
View Top Biotech Stocks

Adma Biologics Stock Forecast FAQ

Is Adma Biologics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: ADMA) stock is to Strong Buy ADMA stock.

Out of 3 analysts, 2 (66.67%) are recommending ADMA as a Strong Buy, 1 (33.33%) are recommending ADMA as a Buy, 0 (0%) are recommending ADMA as a Hold, 0 (0%) are recommending ADMA as a Sell, and 0 (0%) are recommending ADMA as a Strong Sell.

If you're new to stock investing, here's how to buy Adma Biologics stock.

What is ADMA's earnings growth forecast for 2025-2027?

(NASDAQ: ADMA) Adma Biologics's forecast annual earnings growth rate of 10.07% is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.28%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.17%.

Adma Biologics's earnings in 2025 is $197,673,000.On average, 2 Wall Street analysts forecast ADMA's earnings for 2025 to be $168,706,721, with the lowest ADMA earnings forecast at $163,954,419, and the highest ADMA earnings forecast at $173,459,023. On average, 1 Wall Street analyst forecast ADMA's earnings for 2026 to be $220,982,043, with the lowest ADMA earnings forecast at $220,982,043, and the highest ADMA earnings forecast at $220,982,043.

In 2027, ADMA is forecast to generate $268,505,063 in earnings, with the lowest earnings forecast at $268,505,063 and the highest earnings forecast at $268,505,063.

What is ADMA's revenue growth forecast for 2025-2027?

(NASDAQ: ADMA) Adma Biologics's forecast annual revenue growth rate of 20.25% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 65.48%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.37%.

Adma Biologics's revenue in 2025 is $426,454,000.On average, 1 Wall Street analysts forecast ADMA's revenue for 2025 to be $117,809,566,580, with the lowest ADMA revenue forecast at $117,809,566,580, and the highest ADMA revenue forecast at $117,809,566,580. On average, 1 Wall Street analysts forecast ADMA's revenue for 2026 to be $145,301,633,650, with the lowest ADMA revenue forecast at $145,301,633,650, and the highest ADMA revenue forecast at $145,301,633,650.

In 2027, ADMA is forecast to generate $176,904,441,950 in revenue, with the lowest revenue forecast at $176,904,441,950 and the highest revenue forecast at $176,904,441,950.

What is ADMA's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: ADMA) forecast ROA is 70.02%, which is higher than the forecast US Biotechnology industry average of 36.07%.

What is ADMA's Price Target?

According to 3 Wall Street analysts that have issued a 1 year ADMA price target, the average ADMA price target is $25.33, with the highest ADMA stock price forecast at $26.00 and the lowest ADMA stock price forecast at $25.00.

On average, Wall Street analysts predict that Adma Biologics's share price could reach $25.33 by Mar 4, 2026. The average Adma Biologics stock price prediction forecasts a potential upside of 28.99% from the current ADMA share price of $19.64.

What is ADMA's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: ADMA) Adma Biologics's current Earnings Per Share (EPS) is $0.85. On average, analysts forecast that ADMA's EPS will be $0.71 for 2025, with the lowest EPS forecast at $0.69, and the highest EPS forecast at $0.73. On average, analysts forecast that ADMA's EPS will be $0.93 for 2026, with the lowest EPS forecast at $0.93, and the highest EPS forecast at $0.93. In 2027, ADMA's EPS is forecast to hit $1.13 (min: $1.13, max: $1.13).

What is ADMA's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: ADMA) forecast ROE is 98.04%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.